Related Experiment Video
Updated: Dec 28, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History
Haiting Wu1, Xiaoyan Wang2,3, Zhe Yang2
1Division of Nephrology, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Insights
Serum soluble CD89-IgA complexes can aid in diagnosing IgA nephropathy (IgAN) in patients not on immunosuppressants. However, these complexes offer limited value for predicting disease severity.
Area of Science:
- Immunology
- Nephrology
- Biochemistry
Background:
- CD89 (FcαRI) is the IgA receptor, and its soluble form (sCD89) can complex with IgA in serum.
- These sCD89-IgA complexes are implicated in the pathogenesis of IgA nephropathy (IgAN).
- Previous studies on the clinical utility of sCD89-IgA complexes have yielded conflicting results.
Purpose of the Study:
- To investigate the diagnostic and evaluative potential of serum sCD89-IgA complexes in IgA nephropathy.
- To determine if sCD89-IgA complex levels correlate with disease severity in IgAN patients.
Main Methods:
- A sandwich ELISA was developed using anti-CD89 capture antibodies and HRP-conjugated anti-IgA detection antibodies.
- Serum levels of sCD89-IgA complexes were measured in IgAN patients (without prior immunosuppressant treatment) and healthy controls.
- Correlations between sCD89-IgA complex levels and clinicopathological features of IgAN were analyzed.
Main Results:
- Serum sCD89-IgA complex levels showed a positive correlation with age.
- IgAN patients exhibited significantly higher serum sCD89-IgA complex levels compared to age- and gender-matched healthy individuals.
- The study found higher sCD89-IgA complex levels in IgAN patients compared to controls.
Conclusions:
- Serum sCD89-IgA complexes show promise as a diagnostic biomarker for IgA nephropathy in treatment-naïve patients.
- The utility of sCD89-IgA complexes for clinicopathological prediction in IgAN appears limited.
Purpose:
CD89 (FcαRI), the receptor of IgA, can shed from cells to form complexes with IgA in serum and is supposed to participate in the pathogenesis of IgA nephropathy (IgAN). There are contradictory results on their utility in clinical practice. This study is aimed at investigating whether sCD89-IgA complexes can help in the diagnosis or evaluation of the disease.
Methods:
A sandwich ELISA was established using anti-CD89 as a capture antibody and HRP-conjugated anti-IgA as a detection antibody. This method was used to measure serum levels of sCD89-IgA complexes in IgAN patients without immunosuppressant history and healthy subjects. Correlations between serum levels of sCD89-IgA complexes and disease severity were analyzed.
Results:
Serum sCD89-IgA complexes increased with age (P < 0.001). IgAN patients had higher sCD89-IgA complex levels compared with age- and gender-matched normal healthy individuals (P < 0.001). IgAN patients had higher sCD89-IgA complex levels compared with age- and gender-matched normal healthy individuals (P < 0.001). IgAN patients had higher sCD89-IgA complex levels compared with age- and gender-matched normal healthy individuals (.
Conclusions:
Serum sCD89-IgA complexes can guide diagnosis of IgAN in patients without immunosuppressant history, but provide limited help in clinicopathologic prediction.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Nephrotic Syndrome III : Nursing Management

